# Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma

> **NCT03284268** · NA · COMPLETED · sponsor: **Fundació Sant Joan de Déu** · enrollment: 13 (actual)

## Conditions studied

- Retinoblastoma, Recurrent

## Interventions

- **GENETIC:** VCN-01

## Key facts

- **NCT ID:** NCT03284268
- **Lead sponsor:** Fundació Sant Joan de Déu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-06
- **Primary completion:** 2024-06-14
- **Final completion:** 2024-06-14
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03284268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03284268, "Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03284268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*